ShareValue scores for C1OO34.SA: Valuation 40, Quality 22, Growth 47, Health 29.

C1OO34.SA
B3

The Cooper Companies, Inc.

R$37.40(+0.86%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-10% to 12%
Valuation
40
Overvalued
Price vs Value
Quality
22
Weak
Business Strength
Growth
47
Moderate
Revenue & Earnings
Health
29
Stressed
Financial Stability
Momentum
41
Neutral
Price Trend

Company Details

About

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026